Racial disparities in patients with TP53 mutated acute myeloid leukemia.

被引：0
作者：
Badar, Talha
Litzow, Mark Robert
Shallis, Rory
Stahl, Maximilian
Bewersdorf, Jan Philipp
Saliba, Antoine N.
Correia, Guilherme Sacchi De Camargo
Patel, Anand Ashwin
Abaza, Yasmin
Murthy, Guru Subramanian Guru
Duvall, Adam
Burkart, Madelyn
Al-Kali, Aref
Palmisiano, Neil
Dinner, Shira
Goldberg, Aaron David
Atallah, Ehab L.
机构：
[1] Mayo Clin, Jacksonville, FL USA
[2] Mayo Clin, Div Hematol, Rochester, MN USA
[3] Yale Sch Med, New Haven, CT USA
[4] Mem Sloan Kettering Canc Ctr, New York, NY USA
[5] Yale Univ Sch Med, New Haven, CT USA
[6] Mt Sanai Hosp, New York, NY USA
[7] Univ Chicago, Chicago, IL USA
[8] Northwestern Mem Hosp, Chicago, IL USA
[9] Med Coll Wisconsin, Div Hematol Oncol, Milwaukee, WI USA
[10] Univ Chicago Med, Chicago, IL USA
[11] Thomas Jefferson Univ Hosp, Philadelphia, PA USA
[12] Med Coll Wisconsin, Milwaukee, WI USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19007
引用
收藏
页码：E19007 / E19007
页数：1
相关论文
共 50 条
  • [31] Is TP53 Mutated AML the Same Disease as TP53 Mutated MDS?
    Valk, Peter J. M.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S3 - S5
  • [32] TP53 Mutation in Acute Myeloid Leukemia: An Old Foe Revisited
    Shin, Dong-Yeop
    CANCERS, 2023, 15 (19)
  • [33] Clinical implications of subclonal TP53 mutations in acute myeloid leukemia
    Prochazka, Katharina T.
    Pregartner, Gudrun
    Ruecker, Frank G.
    Heitzer, Ellen
    Pabst, Gabriel
    Woelfler, Albert
    Zebisch, Armin
    Berghold, Andrea
    Doehner, Konstanze
    Sill, Heinz
    HAEMATOLOGICA, 2019, 104 (03) : 516 - 523
  • [34] TP53 in Acute Myeloid Leukemia: Molecular Aspects and Patterns of Mutation
    George, Binsah
    Kantarjian, Hagop
    Baran, Natalia
    Krocker, Joseph Douglas
    Rios, Adan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (19)
  • [35] Mutant TP53 prevents Telomere Shortening in Acute Myeloid Leukemia
    Wahida, Adam
    Hutter, Stephan
    Gurnari, Carmelo
    Stainczyk, Sabine
    Pagliuca, Simona
    Meggendorfer, Manja
    Laframboise, Thomas
    Haferlach, Claudia
    Kern, Wolfgang
    Westermann, Frank
    Feuerbach, Lars
    Haferlach, Torsten
    Maciejewski, Jaroslaw P.
    BLOOD, 2021, 138
  • [36] Prognostic Significance of TP53 Mutation Class in Acute Myeloid Leukemia
    Nichols, Meredith
    Jambhekar, Ashwini
    Bell, Timothy
    Nakashima, Megan
    Lovitch, Scott
    LABORATORY INVESTIGATION, 2024, 104 (03) : S1460 - S1461
  • [37] TP53 Mutations in Acute Myeloid Leukemia: Still a Daunting Challenge?
    Molica, Matteo
    Mazzone, Carla
    Niscola, Pasquale
    de Fabritiis, Paolo
    FRONTIERS IN ONCOLOGY, 2021, 10
  • [38] Comparison of acute myeloid leukemia and myelodysplastic syndromes with TP53 aberrations
    Sayantanee Dutta
    Jennifer Moritz
    Gudrun Pregartner
    Gerhard G. Thallinger
    Ilona Brandstätter
    Karin Lind
    Simin Rezania
    Freya Lyssy
    Andreas Reinisch
    Armin Zebisch
    Andrea Berghold
    Albert Wölfler
    Heinz Sill
    Annals of Hematology, 2022, 101 : 837 - 846
  • [39] Therapeutic Vulnerabilities in Acute Myeloid Leukemia (AML) with <it>TP53</it> Alterations
    Ogunsan, Oluwateniayo
    Antony, Marie
    Noble-Orcutt, Klara
    He, Fiona
    Sachs, Zohar
    FASEB JOURNAL, 2020, 34
  • [40] TP53 Mutant Acute Myeloid Leukemia: The Immune and Metabolic Perspective
    Zingarelli, Federico
    Zannoni, Letizia
    Curti, Antonio
    HEMATO, 2022, 3 (04): : 742 - 757
12345